-+ 0.00%
-+ 0.00%
-+ 0.00%

EVOMMUNE SHARES DOWN 11.3% AFTER CO'S ECZEMA DRUG MISSES MAIN GOAL IN MID-STAGE TRIAL

Reuters·09/09/2026 13:44:49

Please log in to view news